85-1559-41 SMOC1, Recombinant, Human, His-Tag (SPARC-related Modular Calcium-binding Protein 1, Secreted Modular Calcium-binding Protein 1, SMOC-1) 50ug S1015-30

※お見積書はカートで印刷できます

冷凍 保管・搬送時に冷凍が必要な商品です。

特徴

  • SMOC-1 (secreted, or SPARC-related, modular calcium-binding protein 1) is a 70-90kD secreted glycoprotein that is a member of the SPARC family of matricellular molecules. Mature human SMOC-1 is 408aa in length. It contains one Kazal-like domain (aa42-87), two thyroglobulin type-1 (TY) segments (aa92-159 and 224-292) and two EF-hand sequences (aa359-394 and 396-431). One potential splice variant contains a 16aa region of alternate sequence between the TY domains, a 7aa deletion between the TY and EF-hand domains, and three alternate aa at the C-terminus. Mature human SMOC-1 shares 92% aa identity with mouse and rat SMOC-1 and 97%, 96% and 95% aa identity with canine, bovine and porcine SMOC-1, respectively. The principal difference between rodents and other mammals is an additional 19aa near the C-terminus of rodent SMOC-1. Like other matricellular proteins, SMOC-1 is primarily expressed in basement membranes, although it has also been found in other extracellular matrices and the oocyte zona pellucida. It is present early in mouse embryogenesis, and is produced by cells deriving from all three germ layers. Recombinant bacterially produced human SMOC-1 and SMOC-2 were both shown to bind the acute phase protein, C-reactive protein, and the adhesion proteins, fibulin and vitronectin. A signaling role for SMOC-1 was shown in rat mesangial cells: induction of nitric oxide in response to inflammatory cytokines downregulates SMOC-1 which, in turn, downregulates expression of TGF-b and TGF-b-regulated genes. This mechanism is proposed to limit the profibrotic effects of TGF-b, for example in the glomerulus. In Xenopus, the SMOC paralog has been shown to antagonize BMP activity.
  • Source:Murine myeloma cell line, NS0-derived His27-Val434, with a C-terminal 6-His tag.
  • SDS-PAGE:60-65kD, reducing conditions
  • Activity:Measured by the ability of the immobilized protein to support the adhesion of A431 human epidermoid carcinoma cells. When 5x10e4 cells/well are added to rhSMOC-1 coated plates, cell adhesion is enhanced in a dose dependent manner after 75 minutes at 37 °C. The ED50 for this effect is typically 0.5-2ug/ml.
  • Endotoxin Level: ≤1EU/1ug (LAL)
  • Storage and Stability:Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with sterile buffer or ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Reconstituted product is stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

  • Size:50ug
  • Source Antigen:Recombinant, NS0-derived, murine myeloma cell line
  • Grade:Highly Purified
  • Purity:~95% (SDS-PAGE, reducing conditions)
  • Form:Supplied as a lyophilized powder from PBS. Reconstitute with sterile PBS.
  • Molecular Weight Non Ab:46
  • Swiss Prot Number:Q9H4F8
  • EU Commodity Code:38220090
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
85-1559-41
型番
S1015-30
入り数
1個
標準価格
276,000円(税抜)
WEB価格
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る